MEK/ERK-mediated proliferation is negatively regulated by P38 map kinase in the human pancreatic cancer cell line, PANC-1. [electronic resource]
- Biochemical and biophysical research communications Mar 2001
- 447-53 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0006-291X
10.1006/bbrc.2001.4595 doi
Cell Cycle--drug effects Cell Division--drug effects DNA, Neoplasm--biosynthesis Enzyme Inhibitors--pharmacology Flavonoids--pharmacology Humans Imidazoles--pharmacology JNK Mitogen-Activated Protein Kinases MAP Kinase Signaling System Mitogen-Activated Protein Kinase Kinases--antagonists & inhibitors Mitogen-Activated Protein Kinases--metabolism Pancreatic Neoplasms--enzymology Phosphorylation Pyridines--pharmacology Tumor Cells, Cultured p38 Mitogen-Activated Protein Kinases